Visual Capitalist November 30, 2024
Marcus Lu

Think everyone and their cousin is already on Ozempic? And surely everyone can stop talking about it now?

Think again.

The weight-loss drug market still has a lot of room to grow, according to latest estimates by Morgan Stanley Research.

We visualize their forecasted value of the global obesity drug market till 2030 and go into a few reasons to explain why it’s trending upwards.

A Tide of Weight Management Drugs Are Coming

Morgan Stanley expects the weight-loss drug market to be worth $77 billion by 2030, more than 5x what it is in 2024.

...
YearU.S. Revenue ($B)Non-US Revenue ($B)Total Revenue ($B)
2024$11$3$15
2025$17

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Biotechnology, Pharma / Biotech
Related Articles:
Gene Therapy Shows Long-Term Vision Benefits in Rare Eye Disease
A Biologist Explains The ‘Weird’ Habits Of People Who Live To 100+ Years Old
U.S. Health Care Spending Reaches $4.9 Trillion
Medicaid spending on weight loss, diabetes drugs up 500% since 2019: 5 numbers to know
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.

Share This Article